This channel includes news on cardiovascular care delivery, including how patients are diagnosed and treated, cardiac care guidelines, policies or legislation impacting patient care, device recalls that may impact patient care, and cardiology practice management.
One of the AI haves feels the pain of the AI have-nots.His discomfort is especially pronounced when he thinks about how hard it must be for financial strugglers to keep up with regulations and rumors of regulations to come.
The AMA is imploring physicians to serve as ‘full partners’ with other AI stakeholders throughout the technology’s life cycle in relevantly equipped clinical devices.
The WVU Heart and Vascular Institute is hosting a two-day symposium focused on exploring the benefits and long-term potential of robotic aortic valve replacement. Fans of the procedure say it represents a safe, effective alternative to TAVR and SAVR in patients with severe aortic stenosis.
A primary aim of medical humanities as a field today is teaching medical students how to harmonize technological innovations with care models such that patients are treated as whole persons: They have not just bodies but also minds, relationships—and lives.
Federal lawmakers have a fresh resource to keep them up on healthcare AI that falls outside of formal FDA oversight. It comes in the form of a new report from the nonprofit Bipartisan Policy Center.
Patients who frequently use AI tend to readily trust AI-assisted diagnoses made by their physicians. Counterintuitively, however, those who would rank themselves among the very best-informed about AI tend to mistrust such diagnoses.
The device covers three vessels at once and can be deployed through the patient's TAVR access site. Researchers shared their first-in-human experience in JACC: Case Reports.
The group highlighted the proven effectiveness of these drugs, especially semaglutide and tirzepatide, while noting that eligibility, affordability and availability will still play key roles in any treatment decisions.